Menu Close

Tag: Bubble

Helping the Fellow Out

After biotech stocks hiccupped on Thursday, April 11, 2014, ISI analyst Mark Schenebaum told the world: “Horrible day in biotech. I’m frankly at a loss for an explanation. And it’s my job to know why. [The reason he gets paid the big bucks – FJS.] Schenebaum “has been following the sector since 2000,” but maybe spent too much time golfing.

RSS
Follow by Email
LinkedIn
Share